Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease
Background Chronic obstructive pulmonary disease (COPD) is a multicomponent condition
that is characterised by airflow obstruction that is not fully reversible and is a major global …
that is characterised by airflow obstruction that is not fully reversible and is a major global …
A systematic review of diagnostic biomarkers of COPD exacerbation
YWR Chen, JM Leung, DD Sin - PloS one, 2016 - journals.plos.org
The aims of this systematic review were to determine which blood-based molecules have
been evaluated as possible biomarkers to diagnose chronic obstructive pulmonary disease …
been evaluated as possible biomarkers to diagnose chronic obstructive pulmonary disease …
Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial
Rationale: Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are
common, associated with acute inflammation, and may increase subsequent cardiovascular …
common, associated with acute inflammation, and may increase subsequent cardiovascular …
Serum uric acid as a predictor of mortality and future exacerbations of COPD
K Bartziokas, AI Papaioannou… - European …, 2013 - publications.ersnet.org
Serum uric acid is increased in respiratory disease, especially in the presence of hypoxia
and systemic inflammation. We evaluated serum uric acid as a biomarker for prediction of …
and systemic inflammation. We evaluated serum uric acid as a biomarker for prediction of …
Is it possible to identify exacerbations of mild to moderate COPD that do not require antibiotic treatment?
M Miravitlles, A Moragas, S Hernández, C Bayona… - Chest, 2013 - Elsevier
Background Anthonisen criteria are widely used to guide the use of antibiotics in
exacerbations of COPD. We evaluated the best predictors of outcomes in exacerbations of …
exacerbations of COPD. We evaluated the best predictors of outcomes in exacerbations of …
Oxidative stress and macrophages: driving forces behind exacerbations of asthma and chronic obstructive pulmonary disease?
LES de Groot, TA Van Der Veen… - … of physiology-lung …, 2019 - journals.physiology.org
Oxidative stress is a common feature of obstructive airway diseases like asthma and chronic
obstructive pulmonary disease (COPD). Lung macrophages are key innate immune cells …
obstructive pulmonary disease (COPD). Lung macrophages are key innate immune cells …
[HTML][HTML] Oxidative and nitrosative stress and histone deacetylase-2 activity in exacerbations of COPD
J Footitt, P Mallia, AL Durham, WE Ho… - Chest, 2016 - Elsevier
Background Respiratory virus infections are commonly associated with COPD
exacerbations, but little is known about the mechanisms linking virus infection to …
exacerbations, but little is known about the mechanisms linking virus infection to …
Increased risk of major adverse cardiac events following the onset of acute exacerbations of COPD
M Reilev, A Pottegård, J Lykkegaard… - …, 2019 - Wiley Online Library
Background and objective Acute exacerbations in chronic obstructive pulmonary disease
(COPD) may trigger major adverse cardiac events (MACE). We aimed to determine whether …
(COPD) may trigger major adverse cardiac events (MACE). We aimed to determine whether …
[HTML][HTML] Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers
G Krommidas, K Kostikas, G Papatheodorou… - Respiratory …, 2010 - Elsevier
BACKGROUND: Various systemic inflammatory markers have been evaluated for their value
in acute exacerbations of chronic obstructive pulmonary disease (COPD). Leptin and …
in acute exacerbations of chronic obstructive pulmonary disease (COPD). Leptin and …
The role of microparticles in chronic obstructive pulmonary disease
Accumulating evidence suggests that cell injury in lung tissues is closely connected to
disease progression in chronic obstructive pulmonary disease (COPD). Microparticles (MPs) …
disease progression in chronic obstructive pulmonary disease (COPD). Microparticles (MPs) …